Author: Hamish Negi - Page 2
Most doctors don't know how much drugs cost - and that's hurting patients. Learn why prescribing decisions are often misinformed by hidden pricing and how real-time EHR tools are starting to change that.
The 180-day exclusivity rule under the Hatch-Waxman Act was meant to speed up generic drug entry-but it often delays competition, keeping prices high. Here's how it works, who benefits, and why reform is overdue.
Antitrust laws in generic drug markets are meant to lower prices and increase access, but big pharma uses legal tricks like pay-for-delay deals and product hopping to block competition. Here’s how it works - and who pays the price.
Statin-induced muscle pain affects up to 30% of users. Learn the difference between myalgia and myositis, why it happens, how it's diagnosed, and what actually works to treat it-without giving up heart protection.
NAFLD and NASH are two stages of fatty liver disease. NAFL is simple fat buildup; NASH includes inflammation and liver damage that can lead to fibrosis and cirrhosis. Early detection and lifestyle changes can reverse progression.
Meglitinides like repaglinide and nateglinide help control blood sugar after meals but carry a high risk of hypoglycemia if meals are skipped. Learn how to use them safely with meal timing, reminders, and monitoring.
Topical meds deliver pain relief with far less risk than oral pills. Learn how systemic absorption differs, why safety profiles vary, and which option is right for your pain.
Corticosteroids quickly reduce inflammation in autoimmune diseases like lupus and rheumatoid arthritis, but long-term use carries serious risks including bone loss, cataracts, and adrenal suppression. Learn how to use them safely.
Liver disease reduces the body's ability to clear drugs, leading to dangerous buildup. Learn how enzyme changes, blood flow loss, and dosing guidelines affect medication safety in cirrhosis and other liver conditions.
Mandatory and permissive substitution laws determine whether pharmacists must or can switch your brand-name prescription to a cheaper generic. These state-by-state rules affect your costs, adherence, and safety - and they’re not the same across the U.S.